Integral Diagnostics Ltd. (AU:IDX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Integral Diagnostics Ltd. has received clearance from the Australian Competition and Consumer Commission for its merger with Capitol Health Limited, following an agreement to divest Capitol’s clinic in Melton, Victoria. With this regulatory hurdle cleared, Capitol will seek court approval to finalize the merger, expected to be completed by December 20, 2024. This development marks a significant step towards the consolidation of two major players in the medical imaging sector in Australia.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.